Viral Hepatitis in Asia and the Pacific

Auteur

Dr. Sun is the Professor of Pharmaceutical Policy. Her research areas focus on pharmaceutical policy analysis and specialized in pharmaco-economics and pharmaco-epidemiology. She received her Ph.D. from the Graduate School of Medical Sciences at the University of Groningen of the Netherlands, MSc. of International Health Policy from London School of Economics of the UK, and Bachelor of Pharmaceutical Chemistry from Peking Medical University of China.

Affiliations and expertise

Professor of Pharmaceutical Policy, Chinese Academy of Medical Sciences and Peking Union Medical College

Dr Chan is the Regional Advisor for Hepatitis/HIV/STI in the World Health Organisation South-east Asia Regional Office (SEARO). She has served in countries and regions with WHO since 2005 in public health and communicable diseases prevention and control. Dr Chan graduated as a medical doctor from the University of Hong Kong, trained in women's health, and in tropical medicine and epidemiology from the London School of Hygiene and Tropical Medicine.

Affiliations and expertise

Regional Advisor for Hepatitis/HIV/STI, World Health Organisation South-east Asia Regional Office (SEARO), Delhi, India.

Ms Chee is the Executive Director of Third World Network, a non-profit international policy research and advocacy organization involved in sustainable development issues. She is an international lawyer whose areas of expertise include the environmental, social and economic impacts of globalization, especially in countries of the South. She holds degrees from the University of Malaya (Malaysia) and Cambridge University (UK).

Affiliations and expertise

Third World Network, Malaysia

Texte du rabat

Viral Hepatitis Elimination in Asia and the Pacific: On the Path of Worldwide Treatment documents the narratives, innovations, and scope of work in the Asia-Pacific region in starting, consolidating, and moving towards the elimination of viral hepatitis. The Asia-Pacific region is disproportionately affected by viral hepatitis, accounting for two-thirds of the global burden. Countries from low-, middle- and high-income economies have adopted different strategies to address combating and eliminating viral hepatitis. The successful experiences of the Asia-Pacific region are valuable for other regions, especially the middle- and low-income countries moving towards the achievement of the 2030 goal of elimination. Strategies discussed include integrated approaches, negotiating universal access to diagnostics, and treatment options, including vaccines. Content further covers the critical barriers to achieve the 2030 targets for elimination of viral hepatitis, and how to overcome them. This is the perfect reference for all hepatology researchers and elimination policy advocates who are dedicated to joining the fight for the 2030 goal of the elimination of viral hepatitis as a public health threat.

Contenu

Viral Hepatitis in Asia and the Pacific: Towards Elimination as a Public Health Threat

Chapter 1 Epidemiology and response to viral hepatitis in Asia and the Pacific regions
Polin Chan1, Tiara Mahatmi Nisa2, Mohamed Amine Ghrabi3, Kiyohiko Izumi4, Amit Goel5, Bharat Bhushan Rewari6
Chapter 2 Hepatitis in Australia
Jisoo A. Kwon1, David C. Boettiger1, David Newby2
Chapter 3 Central pooled procurement and price negotiation: China’s strategy for affordable antivirals treatment of hepatitis B & C
Yihan Fu1, Zhuoran Ma1; Zhitao Wang1; Zhongdan Chen2; Changsong Jiang3; Jing Sun1
Chapter 4 Towards elimination of viral hepatitis in India
Ajeet Singh Bhadoria1, Pallav Bhattacharya2, Pritam Roy3, Gagandeep Grover4, Vineet Kumar Pathak5, Pragya Pandey6
Chapter 5 Hepatitis B Elimination in the Pacific Islands: Models of care delivery in Kiribati
Thomas Russell1, David Hilmers2, Caroline Lee3, and Alice Lee4,5
Chapter 6 Hepatitis B Elimination in the Pacific Islands: Models of care delivery in Kiribati
Thomas Russell1, David Hilmers2, Caroline Lee3, and Alice Lee4,5
Chapter 7 The first lower-middle-income country in the Asia-Pacific region to commit to viral hepatitis elimination
Gereltuya Dorj1, Amarjargal Choijoo2, Chinburen Jigjidsuren3, Chimedsuren Ochir4, Baatarkhuu Oidov5, Gantuya Dorj6, Undram Lkhagvaa6, Nick Walsh7, Javkhlan Jargalsaikhan8, Baasandorj Erdenetsetseg9
Chapter 8 Hepatitis B immunization
Xi Li1, Sigrun Roesel2, Weigong Zhou3
Chapter 9 South-South partnerships in developing affordable DAAs for low- and middle-income countries
Jean-Michel Piedagel1, Han Yang Chung2, Tilak Ramanaidu1, Graciela Diap3, Pascale Boulet3, Mark Wing Loong Cheong3
Chapter 10 The ‘how’ of shifting a global paradigm: from dual to triple elimination of HIV, syphilis and viral hepatitis B
Polin Chan1, Hui Zheng2, Ailing Wang3, Fuzhen Wang2, Jinlin Hou4, Zhihua Liu4, Jidong Jia5, Lai Wei6, Yu Wang7, Timothy Hallett8, Shevanthi Nayagam8, Xiaoyan Wang3, Qian Wang3, Fuqiang Cui9, Daniel Low-Beer10, Philippa Easterbrook8, Zhuang Hui9, Lawrence Everett Rodewald1